Nicole Negar Davarpanah insider trades
Open-market stock purchases and sales by Nicole Negar Davarpanah, Chief Medical Officer at Cidara Therapeutics, Inc, from SEC Form 4 filings since May 1, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $435K |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $2.8M |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | — |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $207K |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $68.5K |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $673K |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $646K |
| Dec 29, 2025 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | — |
| Dec 10, 2025 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $2.3M |
Companies traded
- CDTX Cidara Therapeutics, Inc: 1 sale, last Jan 7, 2026
Get free alerts when Nicole Negar Davarpanah files a new trade →